ArticleFrontiers in immunology2021

TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma.

Itay Raphael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.